Ellen van Drunen
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Molecular Biology top 5%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
Papers in
-
- Chronic Myeloid Leukemia Treatments 7
- Acute Myeloid Leukemia Research 6
- Co-authors
- H. Berna BeverlooRoland KanaarAnton BernsJan H.J. HoeijmakersJos JonkersAlex MaasMagda BudzowskaLaura J. Niedernhofer
- Journals
- Genes Chromosomes and Cancer (9 papers)Blood (3 papers)DNA repair (2 papers)Leukemia (2 papers)International Journal of Cancer (2 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Ellen van Drunen
42 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 115
- Hematology 552
- Molecular Biology 2.5k
- Cancer Research 541
- Oncology 960
- Aging 42
Countries citing papers authored by Ellen van Drunen
This map shows the geographic impact of Ellen van Drunen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen van Drunen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen van Drunen more than expected).
Fields of papers citing papers by Ellen van Drunen
This network shows the impact of papers produced by Ellen van Drunen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen van Drunen. The network helps show where Ellen van Drunen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ellen van Drunen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 258 | |
| 2 | 2011 | 22 | |
| 3 | 2009 | 6 | |
| 4 | 2008 | 20 | |
| 5 | 2007 | 15 | |
| 6 | 2007 | 121 | |
| 7 | 2007 | 18 | |
| 8 | 2007 | 312 | |
| 9 | 2006 | 170 | |
| 10 | 2006 | 59 | |
| 11 | 2006 | 35 | |
| 12 | 2006 | 83 | |
| 13 | 2005 | 14 | |
| 14 | 2004 | 407 | |
| 15 | 2004 | 54 | |
| 16 | 1996 | 102 | |
| 17 | 1995 | 2 | |
| 18 | 1994 | 11 | |
| 19 | 1989 | 85 | |
| 20 | 1989 | 50 |
About Ellen van Drunen
Ellen van Drunen is a scholar working on Hematology, Immunology and Allergy, Ophthalmology, Cancer Research and Genetics, having authored 42 papers that have together received 3.7k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (10 papers), Chronic Myeloid Leukemia Treatments (7 papers), Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (6 papers), Carcinogens and Genotoxicity Assessment (5 papers), Testicular diseases and treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Ocular Oncology and Treatments (4 papers). The work is most often cited by research in Hematology (552 citations), Molecular Biology (2.5k citations), Cancer Research (541 citations), Oncology (960 citations) and Aging (42 citations). Ellen van Drunen has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include H. Berna Beverloo, Roland Kanaar, Anton Berns, Jan H.J. Hoeijmakers, Jos Jonkers, Alex Maas, Magda Budzowska, Laura J. Niedernhofer, Marc Vooijs and Jeroen Essers. Their work appears in journals such as Genes Chromosomes and Cancer, Blood, DNA repair, Leukemia and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.